1. Aizenshtadt, A.A., Skazina, M.A., Kotelevskaya, E.A., Yelsukova, L.V., Zolina, T.L., Ponomartsev, N.V., Galaktionov, N.K., Galembo, I.A., Ivolgin, D.A., Maslennikova, I.I., and Enukashvily, N.I., Charachterization of umbilical cord mesenchymal stromal cells during long-term expansion in vitro, Vestn. Sev.-Zap. Gos. Med. Univ.
im.
I.I. Mechnikova, 2018, vol. 10, no. 1, p. 11.
2. Baranov, V.S. and Kuznetsova, T.V., Tsitogenetika embrional’nogo razvitiya cheloveka: nauchno-prakticheskie aspekty (Cytogenetics of Human Embryonic Development: Scientific and Practical Aspects), St. Petersburg: Izd. N-L, 2007.
3. Barkholt, L., Flory, E., Jekerle, V., Lucas-Samuel, S., Ahnert, P., Bisset, L., Buscher, D., Fibbe, W., Foussat, A., Kwa, M., Lantz, O., Mačiulaitis, R., Palomäki, T., Schneider, C.K., Sensebé, L., et al., Risk of tumorigenicity in mesenchymal stromal cell-based therapies—bridging scientific observations and regulatory viewpoints, Cytotherapy, 2013, vol. 15, p. 753.
4. Bauer, G., Elsallab, M., and Abou-El-Enein, M., Concise review: a comprehensive analysis of reported adverse events in patients receiving unproven stem cell-based interventions, Stem Cells Transl. Med., 2018, vol. 7, p. 676.
5. Bochkov, N.P. and Chebotarev, A.N., Nasledstvennost’ cheloveka i mutageny vneshnei sredy (Human Heredity and Environmental Mutagens), Moscow: Meditsina, 1989.